Moderna stock is a “Hold” due to persistent unprofitability, negative free cash flow, and a valuation highly dependent on pipeline execution. Read the full analysis here.
Moderna: Best S&P 500 Stock YTD Could Rally Into YE, But Valuation Is Uncertain
view original post